Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bile Acids and Microbiome - Possible Novel Progression Factors and Diagnostic Indicators in Early Colorectal Carcinogenesis

NCT06502704 is registered in ClinicalTrials.gov with Vilnius University as lead sponsor.

NCT NCT06502704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06502704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bile Acids and Microbiome - Possible Novel Progression Factors and Diagnostic Indicators in Early Colorectal Carcinogenesis
Lead sponsor
Vilnius University
Phase
Observational
Overall status
Unknown status
Start date
July 5, 2024
Completion date
January 1, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bile acid malabsorption, colorectal cancer, colorectal neoplasms, colorectal polyp, microbiome